Adaptive Biotechnologies Corporation (ADPT) Stock Overview
Explore Adaptive Biotechnologies Corporation’s financial performance, market position, analyst ratings, and future outlook.
Adaptive Biotechnologies Corporation (ADPT)
Key Financials
Key Financials
Market Cap
4.2B
P/E Ratio
-63.43
EPS (TTM)
$-0.41
ROE
-0.33%
ADPT Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Adaptive Biotechnologies Corporation (NASDAQ: ADPT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Adaptive Biotechnologies Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ADPT on the NASDAQ shows an RSI of 65.54, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $24.78 for the NASDAQ listing.
Key metrics behind Adaptive Biotechnologies Corporation's NASDAQ-traded stock include a P/E ratio of -63.43 and a market capitalization of 4.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ADPT on the NASDAQ.